GFRA1 and neoplasm: The interaction between GDNF and its receptor, GFRα1, may affect tumour cell behaviour and contribute to the aggressive nature of OS.24 This signalling pathway has been linked to increased tumour cell viability and resistance to apoptosis, which can exacerbate the disease.